404 related articles for article (PubMed ID: 28271875)
1. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
[TBL] [Abstract][Full Text] [Related]
2. Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis.
Gopal P; Yee M; Sarathy J; Low JL; Sarathy JP; Kaya F; Dartois V; Gengenbacher M; Dick T
ACS Infect Dis; 2016 Sep; 2(9):616-626. PubMed ID: 27759369
[TBL] [Abstract][Full Text] [Related]
3. Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis.
Yee M; Gopal P; Dick T
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872068
[TBL] [Abstract][Full Text] [Related]
4. Pyrazinamide triggers degradation of its target aspartate decarboxylase.
Gopal P; Sarathy JP; Yee M; Ragunathan P; Shin J; Bhushan S; Zhu J; Akopian T; Kandror O; Lim TK; Gengenbacher M; Lin Q; Rubin EJ; Grüber G; Dick T
Nat Commun; 2020 Apr; 11(1):1661. PubMed ID: 32245967
[TBL] [Abstract][Full Text] [Related]
5. Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.
Gopal P; Nartey W; Ragunathan P; Sarathy J; Kaya F; Yee M; Setzer C; Manimekalai MSS; Dartois V; Grüber G; Dick T
ACS Infect Dis; 2017 Nov; 3(11):807-819. PubMed ID: 28991455
[TBL] [Abstract][Full Text] [Related]
6. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis.
Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Mutations in LprG (
Shi W; Chen J; Zhang S; Zhang W; Zhang Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686155
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
9. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
Shi W; Chen J; Feng J; Cui P; Zhang S; Weng X; Zhang W; Zhang Y
Emerg Microbes Infect; 2014 Aug; 3(8):e58. PubMed ID: 26038753
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
[TBL] [Abstract][Full Text] [Related]
11. Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis.
Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
Gene; 2016 Apr; 581(1):31-42. PubMed ID: 26784657
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD.
Sun Q; Li X; Perez LM; Shi W; Zhang Y; Sacchettini JC
Nat Commun; 2020 Jan; 11(1):339. PubMed ID: 31953389
[TBL] [Abstract][Full Text] [Related]
13. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
14. Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.
Zhang S; Chen J; Shi W; Liu W; Zhang W; Zhang Y
Emerg Microbes Infect; 2013 Jun; 2(6):e34. PubMed ID: 26038471
[TBL] [Abstract][Full Text] [Related]
15.
Ragunathan P; Cole M; Latka C; Aragaw WW; Hegde P; Shin J; Subramanian Manimekalai MS; Rishikesan S; Aldrich CC; Dick T; Grüber G
ACS Chem Biol; 2021 Jun; 16(6):1030-1039. PubMed ID: 33984234
[TBL] [Abstract][Full Text] [Related]
16. Structural and Mechanistic Insights into
Saw WG; Leow CY; Harikishore A; Shin J; Cole MS; Aragaw WW; Ragunathan P; Hegde P; Aldrich CC; Dick T; Grüber G
ACS Infect Dis; 2022 Jul; 8(7):1324-1335. PubMed ID: 35731701
[No Abstract] [Full Text] [Related]
17. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
19. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
Sheen P; Lozano K; Gilman RH; Valencia HJ; Loli S; Fuentes P; Grandjean L; Zimic M
Tuberculosis (Edinb); 2013 Sep; 93(5):515-22. PubMed ID: 23867321
[TBL] [Abstract][Full Text] [Related]
20. High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
Lanoix JP; Tasneen R; O'Brien P; Sarathy J; Safi H; Pinn M; Alland D; Dartois V; Nuermberger E
Antimicrob Agents Chemother; 2016 Jul; 60(7):4197-205. PubMed ID: 27139472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
